MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CRSP — CRISPR Therapeutics AG
NasdaqCRISPR Therapeutics AG
$55.43
-0.01(-0.02%)
- O
- 56.45
- H
- 57.58
- L
- 54.09
- V
- 1.13M
⏱️ End-of-day dataAs of Oct 2, 2026
CRSP — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 423,308.00 | 347,559.00 | 286,497.00 | 193,618.00 | 235,184.00 | 298,257.00 |
| Other Short Term Investments | $2.02M | $1.63M | $1.63M | $1.53M | $1.62M | $1.61M |
| Other Current Assets | 6,577.00 | 9,843.00 | 13,382.00 | 12,429.00 | 12,326.00 | 8,306.00 |
| Total Current Assets | $2.45M | $1.99M | $1.93M | $1.73M | $1.87M | $1.94M |
| Properties | 172,791.00 | 175,299.00 | 176,556.00 | 179,893.00 | 182,481.00 | 185,469.00 |
| Machinery Furniture Equipment | 12,706.00 | 12,706.00 | 12,898.00 | 12,898.00 | 12,802.00 | 12,387.00 |
| Construction In Progress | 4,024.00 | 3,955.00 | 5,797.00 | 5,523.00 | 5,536.00 | 6,118.00 |
| Leases | 146,667.00 | 146,667.00 | 145,852.00 | 145,852.00 | 145,852.00 | 145,852.00 |
| Accumulated Depreciation | -95,342.00 | -91,052.00 | -85,613.00 | -81,599.00 | -76,968.00 | -72,272.00 |
| Other Non Current Assets | 36,612.00 | 31,997.00 | 32,314.00 | 33,478.00 | 28,788.00 | 27,348.00 |
| Total Non Current Assets | 277,458.00 | 279,572.00 | 316,216.00 | 296,045.00 | 298,491.00 | 304,902.00 |
| Total Assets | $2.73M | $2.27M | $2.25M | $2.03M | $2.17M | $2.24M |
| Accounts Payable | 13,647.00 | 11,138.00 | 11,798.00 | 9,753.00 | 13,064.00 | 14,709.00 |
| Accrued Expenses | 74,932.00 | 89,407.00 | 84,182.00 | 73,738.00 | 84,615.00 | 41,072.00 |
| Short Term Debt | 18,612.00 | 18,578.00 | 18,256.00 | 18,027.00 | 17,506.00 | 17,288.00 |
| Deferred Revenue | 15,344.00 | 15,771.00 | 1,295.00 | 2,129.00 | 3,021.00 | 3,845.00 |
| Tax Payable | 638.00 | 1,113.00 | 3,426.00 | 715.00 | 1,241.00 | 451.00 |
| Other Current Liabilities | 13,113.00 | 13,113.00 | N/A | N/A | N/A | 10,417.00 |
| Total Current Liabilities | 136,286.00 | 149,120.00 | 118,957.00 | 104,362.00 | 119,447.00 | 87,782.00 |
| Long Term Debt | 769,030.00 | 188,168.00 | 192,768.00 | 197,425.00 | 201,852.00 | 206,405.00 |
| Other Non Current Liabilities | 5,948.00 | 6,142.00 | 5,278.00 | 4,476.00 | 3,320.00 | 3,444.00 |
| Total Non Current Liabilities | 774,978.00 | 194,310.00 | 210,369.00 | 214,224.00 | 217,495.00 | 222,172.00 |
| Total Liabilities | 911,264.00 | 343,430.00 | 329,326.00 | 318,586.00 | 336,942.00 | 309,954.00 |
| Common Stock | 3,115.00 | 3,087.00 | 3,013.00 | 2,794.00 | 2,721.00 | 2,698.00 |
| Retained Earnings | $-2.07M | $-1.95M | $-1.82M | $-1.71M | $-1.50M | $-1.37M |
| Other Shareholders Equity | -1,941.00 | 4,821.00 | 4,986.00 | 4,041.00 | 4,135.00 | 1,840.00 |
| Total Shareholders Equity | $1.81M | $1.92M | $1.92M | $1.71M | $1.83M | $1.93M |
| Additional Paid In Capital | $3.88M | $3.86M | $3.72M | $3.41M | $3.32M | $3.29M |
| Treasury Stock | 60.00 | 60.00 | 60.00 | 62.00 | 62.00 | 62.00 |
| Accounts Receivable | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 25,000.00 |
| Investments And Advances | N/A | N/A | 28,412.00 | N/A | N/A | 0.00 |
| Goodwill | N/A | N/A | N/A | N/A | N/A | 0.00 |